Maini CL - Search Results

1

Delayed thyroid-stimulating hormone suppression by L-thyroxine in the management of differentiated thyroid carcinoma.

Maini CL, Sciuto R, Tofani A. Maini CL, et al. Eur J Cancer. 1993;29A(14):2071-2. doi: 10.1016/0959-8049(93)90477-w. Eur J Cancer. 1993. PMID: 8280504 No abstract available.

2

Thyroid-stimulating hormone (TSH) suppression in differentiated thyroid carcinoma: combined treatment with triiodothyronine and thyroxine.

Maini CL, Sciuto R, Tofani A, Rosito I, Franciotti G, Pisano L. Maini CL, et al. Eur J Cancer. 1994;30A(14):2184-5. doi: 10.1016/0959-8049(94)00428-8. Eur J Cancer. 1994. PMID: 7857722 No abstract available.

3

TSH suppression by octreotide in differentiated thyroid carcinoma.

Maini CL, Sciuto R, Tofani A. Maini CL, et al. Clin Endocrinol (Oxf). 1994 Mar;40(3):335-9. doi: 10.1111/j.1365-2265.1994.tb03928.x. Clin Endocrinol (Oxf). 1994. PMID: 8187297 Clinical Trial.

4

Myocardial 123I-MIBG kinetics in acutely hypothyroid patients with differentiated thyroid carcinoma.

Maini CL, Tofani A, Sciuto R, Ferraironi A, Festa A, Rea S. Maini CL, et al. Nucl Med Commun. 1999 Aug;20(8):719-26. doi: 10.1097/00006231-199908000-00006. Nucl Med Commun. 1999. PMID: 10451880

5

Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma.

Tofani A, Sciuto R, Cioffi RP, Pasqualoni R, Rea S, Festa A, Gandolfo GM, Arista MC, Maini CL. Tofani A, et al. Among authors: maini cl. Eur J Nucl Med. 1999 Aug;26(8):824-9. doi: 10.1007/s002590050455. Eur J Nucl Med. 1999. PMID: 10436194

6

Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution.

Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL. Sciuto R, et al. Among authors: maini cl. Ann Oncol. 2009 Oct;20(10):1728-35. doi: 10.1093/annonc/mdp050. Ann Oncol. 2009. PMID: 19773250 Free article.

7

Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89.

Sciuto R, Maini CL, Tofani A, Fiumara C, Scelsa MG, Broccatelli M. Sciuto R, et al. Among authors: maini cl. Nucl Med Commun. 1996 Sep;17(9):799-804. doi: 10.1097/00006231-199609000-00011. Nucl Med Commun. 1996. PMID: 8895908 Clinical Trial.

8

Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma.

Maini CL, Tofani A, Sciuto R, Carpano S, Crecco M, Manni C, Lopez M. Maini CL, et al. Clin Nucl Med. 1994 Jul;19(7):607-10. doi: 10.1097/00003072-199407000-00010. Clin Nucl Med. 1994. PMID: 7924102

9

High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.

Bartenstein P, Calabuig EC, Maini CL, Mazzarotto R, Muros de Fuentes MA, Petrich T, Rodrigues FJ, Vallejo Casas JA, Vianello F, Basso M, Balaguer MG, Haug A, Monari F, Vaňó RS, Sciuto R, Magner J. Bartenstein P, et al. Among authors: maini cl. Thyroid. 2014 Mar;24(3):480-7. doi: 10.1089/thy.2013.0157. Epub 2014 Jan 17. Thyroid. 2014. PMID: 24040896

10

[Immunoscintigraphy with 111-indium-labelled antimyosin antibodies in the assessment of muscle metastases. A case report].

Ferraironi A, Tofani A, Sciuto R, Cucchi R, Crecco M, Maini CL. Ferraironi A, et al. Among authors: maini cl. Radiol Med. 1994 Jan-Feb;87(1-2):165-8. Radiol Med. 1994. PMID: 8128026 Italian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters